Principal Investigators

Kim Mulholland

Kim Mulholland


Murdoch Children’s Research Institute
Melbourne, Australia
London School of Hygiene and Tropical Medicine
London, UK
Katherine L. O’Brien

Katherine L. O’Brien


Johns Hopkins Bloomberg School of Public Health
Baltimore, USA

 

Project Team

Nicholas Fancourt


Johns Hopkins Bloomberg School of Public Health
Baltimore, USA
Murdoch Children’s Research Institute
Melbourne, Australia

John de Campo


Murdoch Children’s Research Institute
Melbourne, Australia
Melbourne University
Melbourne, Australia

Margaret de Campo


Murdoch Children’s Research Institute
Melbourne, Australia
Melbourne University
Melbourne, Australia

Stephen Lacey

Quality and Safety Lead
Royal Children’s Hospital
Melbourne, Australia

Claire von Mollendorf


Murdoch Children’s Research Institute
Melbourne Australia
University of Melbourne
Melbourne, Australia

Adam Cohen


World Health Organization
Geneva, Switzerland

Nasreen Mahomed


Department of Radiology University of the Witwatersrand
Johannesburg, South Africa
Medical Research Council: Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand
Johannesburg, South Africa

Haset Samuel

Project Secretariat
Murdoch Children’s Research Institute
Melbourne Australia

 

Technical Working Group

Nasreen Mahomed


Department of Radiology University of the Witwatersrand
Johannesburg, South Africa
Medical Research Council: Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand
Johannesburg, South Africa

Aliu Akano


National Hospital Abuja
Nigeria

Thomas Cherian


Independent Consultant
Geneva, Switzerland

David Greenberg


Soroka University Medical Center
Beer-Sheva, Israel

Neera Kohli


King George Medical University
Lucknow, India

Henrique M. Lederman


Hospital Sao Paulo, Paulista School of Medicine
Sao Paulo, Brazil

Shabir A. Madhi


Medical Research Council: Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand
Johannesburg, South Africa
Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, University of the Witwatersrand
Johannesburg, South Africa

Veronica Manduku


Kenya Medical Research Institute (KEMRI)
Nairobi, Kenya

Eric D. McCollum


Johns Hopkins Bloomberg School of Public Health
Baltimore, USA
Johns Hopkins School of Medicine, Eudowood Division of Pediatric Respiratory Sciences
Baltimore, USA

Kate Park


Oxford University Hospitals NHS Foundation Trust
Oxford, UK

Jose Luis Ribo-Aristizabal


Hospital Sant Joan de Déu
Barcelona, Spain

Naor Bar-Zeev


International Vaccine Access Center
Department of International Health
Johns Hopkins Bloomberg School of Public Health
Baltimore, USA
Malawi-Liverpool-Wellcome Trust Clinical Research Programme
Blantyre, Malawi

Nicholas Fancourt


Johns Hopkins Bloomberg School of Public Health
Baltimore, USA
Murdoch Children’s Research Institute
Melbourne, Australia

John de Campo


Murdoch Children’s Research Institute
Melbourne, Australia
Melbourne University
Melbourne, Australia

Margaret de Campo


Murdoch Children’s Research Institute
Melbourne, Australia
Melbourne University
Melbourne, Australia

Brad Gessner

Scientific Director and Chief Epidemiologist
Agence de Médecine Préventive (AMP), France
Current role: Vice President Global Medical Lead for Pneumococcal Vaccines, Pfizer